Clinical Trial Update: Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing megestrol acetate alone versus megestrol acetate plus metformin to prevent endometrial cancer; current status is active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Atypical Hyperplasia Endometrioid Intraepithelial Neoplasia
• Endometrial Carcinoma

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• metformin (metformin)

Snippet

Sponsor: Northwestern University | Conditions: Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING